Development and validation of an LC-MS/MS method for determination of 8-iso-prostaglandin F2 alpha in human saliva

LC-MS/MS METHOD FOR 8-isoPGF2α DETERMINATION IN SALIVA

  • Zlatina Tomova Department of Prosthetic dental medicine, Faculty of Dental medicine, Medical University of Plovdiv, Bulgaria
  • Desislav Tomov
  • Angelina Vlahova
  • Veneta Chaova-Gizdakova
  • Lyubka Yoanidu
  • Dobrin Svinarov
Keywords: metal alloy, 8-isoPGF2α, LC-MS/MS, saliva, SALLE

Abstract


Background. Increased formation of reactive oxygen species may be caused by the ion release of the metal alloys used in prosthetic dental restorations due to corrosion process. Isoprostanes, as products of lipid peroxidation, can be used as a marker for oxidative stress in the body. There are two big advantages of using isoprostanes as oxidative stress marker – presence in all fluids in the body and low reactivity. Saliva provides non-invasive, painless, and cost-effective sample collection and can be used as an alternative testing medium of blood and urine. Methods. This study presents the development and validation of a sample LC-MS/MS method for quantification of 8-isoprostaglandin F2-α in human saliva using salt-out assisted liquid-liquid extraction (SALLE). Results. The selected sample preparation procedure optimized chromatographic separation and mass detection provided high recovery and sensitivity of the analysis. The calibration curve was obtained in the predefined range 25 – 329 ng/L with R2 larger than 0.995. Normalized matrix varied between 89.7 % and 113.5%. The method showed sufficient accuracy and precision - accuracy in the range 89.7 % – 113.9 %, and precision between 2.3% and 5.4%. Conclusion. The proposed method is validated according to current EMA/FDA industrial guidance for bioanalysis and offers an appropriate level of sensitivity as well as sufficient accuracy and precision.

References

1. Roberts HW, Berzins DW, Moore BK, Charlton DG. Metal-ceramic alloys in dentistry: a review. J Prosthodont 2009 Feb, 18(2):188-94.
2. Takaichi A, Suyalatu, Nakamoto T, Joko N, Nomura N, Tsutsumi Y, et al. Microstructures and mechanical properties of Co-29Cr-6Mo alloy fabricated by selective laser melting process for dental applications. J Mech Behav Biomed Mater. 2013 May;21:67-76.
3. Hedberg YS, Qian B, Shen Z, Virtanen S, Wallinder IO. In vitro biocompatibility of CoCrMo dental alloys fabricated by selective laser melting. Dent Mater. 2014 May;30(5):525-34.
4. Xin XZ, Chen J, Xiang N, Wei B. Surface properties and corrosion behavior of Co-Cr alloy fabricated with selective laser melting technique. Cell Biochem Biophys. 2013;67(3):983-90.
5. Zeng L, Xiang N, Wei B. A comparison of corrosion resistance of cobalt-chromium-molybdenum metal ceramic alloy fabricated with selective laser melting and traditional processing. J Prosthet Dent. 2014 Nov;112(5):1217-24.
6. Schedle A, Samorapoompichit P, Rausch-Fan XH, Franz A, Füreder W, Sperr WR, et al. Response of L-929 fibroblasts, human gingival fibroblasts, and human tissue mast cells to various metal cations. J Dent Res. 1995 Aug;74(8):1513-20.
7. Jomova K, Valko M. Advances in metal-induced oxidative stress and human disease. Toxicology. 2011 May 10;283(2-3):65-87.
8. Battaglia V, Compagnone A, Bandino A, Bragadin M, Rossi CA, Zanetti F, et al. Cobalt induces oxidative stress in isolated liver mitochondria responsible for permeability transition and intrinsic apoptosis in hepatocyte primary cultures. Int J Biochem Cell Biol. 2009 Mar;41(3):586-94.
9. Akbar M, Brewer JM, Grant MH. Effect of chromium and cobalt ions on primary human lymphocytes in vitro. J Immunotoxicol. 2011 Jun;8(2):140-9.
10. Yang S, Lian G. ROS and diseases: role in metabolism and energy supply. Mol. Cell. Biochem. 2020; 467:1–12.
11. Catalá A. Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions.Chem. Phys. Lipids. 2009; 157:1–11.
12. Milne GL, Dai Q, Roberts LJ. The isoprostanes - 25 years later. Biochim. Biophys. Acta - Mol. Cell Biol. Lipids. 2015; 1851:433–445.
13. Su H, Gornitsky M, Velly AM, Yu H, Benarroch M, Schipper HM. Salivary DNA, lipid, and protein oxidation in nonsmokers with periodontal disease. Free Radic. Biol. Med. 2009; 46:914–921.
14. Yoshizawa JM, Schafer CA, Schafer JJ, Farrell JJ, Paster BJ, Wong DTW. Salivary biomarkers: Toward future clinical and diagnostic utilities. Clin. Microbiol. Rev. 2013; 26:781–791.
15. Malamud D. Saliva as a Diagnostic Fluid. Dent. Clin. North Am. 2011; 55:159–178.
16. Bilancio G, Cavallo P, Lombardi C, Guarino E, Cozza V, Giordano F, et al. Saliva for assessing creatinine, uric acid, and potassium in nephropathic patients. BMC Nephrol. 2019; 20:1–9.
17. Mohammadnejad P, Asl SS, Aminzadeh S, Haghbeen K. A new sensitive spectrophotometric method for determination of saliva and blood glucose. Spectrochim. Acta - Part A Mol. Biomol. Spectrosc. 2020; 229: 117897.
18. MacMullan MA, Ibrayeva A, Trettner K, Deming L, Das S, Tran F, et al. ELISA detection of SARS-CoV-2 antibodies in saliva. Sci. Rep. 2020; 10:1–8.
19. Ramírez-De los Santos S, López-Pulido EI, del C. Medrano-González I, Becerra-Ruiz JS, Alonso-Sanchez CC, Vázquez-Jiménez SI, et al. Alteration of cytokines in saliva of children with caries and obesity. Odontology. 2021; 109:11–17.
20. Koregol AC, Kalburgi NB, Kanniappa Sadasivan S, Warad S, Kamat Wagh A, Thomas T, et al. 8-Isoprostane in chronic periodontitis and type II diabetes: Exploring the link. J Dent Res Dent Clin Dent Prospects. 2018 Fall;12(4):252-257.
21. Hösli R, König S, Mühlebach SF. Development and validation of an LC-MS/MS method and comparison with a GC-MS method to measure phenytoin in human brain dialysate, blood, and saliva. J. Anal. Methods Chem. 2018 (2018).
22. Flarakos J, Luo W, Aman M, Svinarov D, Gerber N, Vouros P. Quantification of risperidone and 9-hydroxyrisperidone in plasma and saliva from adult and pediatric patients by liquid chromatography-mass spectrometry. J. Chromatogr. A. 2004; 1026:175–183.
23. Georgiev O, Marinov K, Svinarov D, Noneva D. [Therapeutic drug monitoring of theophylline in the serum and saliva]. Vutr. Boles. 1989; 28:42–45.
24. Van Faassen M, Bischoff R, Kema IP. Relationship between plasma and salivary melatonin and cortisol investigated by LC-MS/MS. Clin. Chem. Lab. Med. 2017; 55:1340–1348.
25. Liu XY, Luo Y, Zhou CY, Peng A, Liu JY. A sensitive and accurate method to simultaneously measure uric acid and creatinine in human saliva by using LC–MS/MS. Bioanalysis. 2017; 9:1751–1760.
26. Marín-Martínez L, Molino-Pagán D, López-Jornet P. Trace elements in saliva and plasma of patients with type 2 diabetes: Association to metabolic control and complications. Diabetes Res. Clin. Pract. 2019; 157.
27. ЕМА, Guideline on bioanalytical method validation. EMEA/CHMP/EWP/192217/2009, 2009. Www.ema.europa.eu.
28. FDA, Guidance for industry: bioanalytical method validation. FDA-2013-D-1020, 2018. Www.fda.gov.
29. Wishart DS, Feunang YD, Marcu A, Guo AC, Liang K, Vázquez-Fresno R, et al. HMDB 4.0: The human metabolome database for 2018, Nucleic Acids Res.2018; 46: D608–D617.
30. Tomov D, Bocheva G, Divarova V, Kasabova L, Svinarov D. Phase separation liquid-liquid extraction for the quantification of 8-iso-Prostaglandin F2 Alpha in human plasma by LC-MS/MS. J. Med. Biochem. 2021; 40:10–16.
Published
2022/04/18
Section
Original paper